Ward M C, Roberts K R, Westwood J H, Coombes R C, McCready V R
J Nucl Med. 1986 Nov;27(11):1746-50.
The potential for altering the biodistribution of radiolabel from gallium- and indium-labeled mouse monoclonal antibodies was investigated in mice using metal chelating agents. The chelating agents used were desferrioxamine (DFO), diethylenetriaminepentaacetic acid (DTPA), ethylenediamine-di (O-hydroxyphenylacetic acid) (EDHPA), and 2,2' dipyridyl (DIPY). The mouse monoclonal antibody LICR-LON-M8 was labeled with 111In after conjugation to DTPA, and with 67Ga after conjugation to DFO. All the chelating agents except DIPY altered the biodistribution of [67Ga]citrate and [111In]citrate but did not affect the 48-hr tissue uptake of label from [111In]DTPA-M8 or [67Ga]DFO-M8, confirming the in vivo stability of the antibody conjugates. Label fixed in the tissues was inaccessible to the chelating agents, indicating that they will not be suitable for reducing the high background liver radioactivity in patients undergoing scanning with indium-labeled antibodies.
使用金属螯合剂在小鼠中研究了改变镓和铟标记的小鼠单克隆抗体放射性标记生物分布的可能性。所使用的螯合剂有去铁胺(DFO)、二乙三胺五乙酸(DTPA)、乙二胺 - 二(O - 羟基苯乙酸)(EDHPA)和2,2' - 联吡啶(DIPY)。小鼠单克隆抗体LICR - LON - M8与DTPA偶联后用111In标记,与DFO偶联后用67Ga标记。除DIPY外,所有螯合剂均改变了[67Ga]柠檬酸盐和[111In]柠檬酸盐的生物分布,但不影响[111In]DTPA - M8或[67Ga]DFO - M8在48小时的组织放射性摄取,证实了抗体偶联物在体内的稳定性。螯合剂无法作用于固定在组织中的标记物,这表明它们不适用于降低接受铟标记抗体扫描的患者肝脏中的高本底放射性。